lobbying_activities: 2265033
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2265033 | d07d873e-677a-445a-86f2-9c1d14b69795 | Q1 | 340B HEALTH | 316434 | 340B HEALTH | 2019 | first_quarter | PHA | The 340B Drug Pricing Program; FY 2020 L-HHS Appropriations; final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 274078 | 0 | 0 | 2019-04-12T17:31:48.787000-04:00 |